EP0030838A1 - Article en caoutchouc de silicone rempli d'un gel de silicone avec exsudation réduite - Google Patents

Article en caoutchouc de silicone rempli d'un gel de silicone avec exsudation réduite Download PDF

Info

Publication number
EP0030838A1
EP0030838A1 EP80304431A EP80304431A EP0030838A1 EP 0030838 A1 EP0030838 A1 EP 0030838A1 EP 80304431 A EP80304431 A EP 80304431A EP 80304431 A EP80304431 A EP 80304431A EP 0030838 A1 EP0030838 A1 EP 0030838A1
Authority
EP
European Patent Office
Prior art keywords
container
silicone gel
silicone
bleed
article
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
EP80304431A
Other languages
German (de)
English (en)
Other versions
EP0030838B1 (fr
Inventor
Willard Dale Larson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dow Silicones Corp
Original Assignee
Dow Corning Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dow Corning Corp filed Critical Dow Corning Corp
Publication of EP0030838A1 publication Critical patent/EP0030838A1/fr
Application granted granted Critical
Publication of EP0030838B1 publication Critical patent/EP0030838B1/fr
Expired legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/50—Prostheses not implantable in the body
    • A61F2/52—Mammary prostheses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02—Prostheses implantable into the body
    • A61F2/12—Mammary prostheses and implants
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L83/00—Compositions of macromolecular compounds obtained by reactions forming in the main chain of the macromolecule a linkage containing silicon with or without sulfur, nitrogen, oxygen or carbon only; Compositions of derivatives of such polymers
    • C08L83/04—Polysiloxanes
    • C08L83/08—Polysiloxanes containing silicon bound to organic groups containing atoms other than carbon, hydrogen and oxygen
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29C—SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
    • B29C41/00—Shaping by coating a mould, core or other substrate, i.e. by depositing material and stripping-off the shaped article; Apparatus therefor
    • B29C41/02—Shaping by coating a mould, core or other substrate, i.e. by depositing material and stripping-off the shaped article; Apparatus therefor for making articles of definite length, i.e. discrete articles
    • B29C41/14—Dipping a core

Definitions

  • This invention relates to silicone gel-filled silicone rubber articles.
  • Brill teaches that the prior art silicone g el-filled silicone rubber containers have an undesirable amount of oiling or bleed because in order to obtain the desired penetration values for the gel with the appropriate natural simulated characteristics, large amounts of unreacted fluid were included in the gel network. Components present in these fluids can then bleed through the silicone rubber container walls to cause the above problem. Brill's solution to the bleed problem resides in utilizing a particular type of silicone gel as a filing material.
  • a great deal of effort has been made in years past to develop silicone gel compositions with the proper characteristics and many silicone gel compositions are commercially available. Proper characteristics, such as penetration values, are extremely important when the article is to be used as a mammary prosthesis.
  • Pangman in U.S. Patent No. 3,366,975 issued February 6, 1968.
  • Pangman teaches a prosthesis which consists of (a) a foam type plastic or silicone sponge core which can also be filled with a silicone gel, (b) a barrier membrane which is typically a silicone polymer, surrounding and bound to the core which is impervious to cellular tissue and fluids and (c) an open cell foam layer covering the membrane which can be invaded by body tissue.
  • a similar type of prosthesis provided with a means for changing the quantity of fluid inside the core is described by Pangman in U.S. Patent No. 3,683,424 issued August 15, 1972.
  • the above patents to Pangman neither address the problem nor do they suggest a means for reducing the surface-bleed of an article comprising a silicone gel-filled silicone rubber container.
  • a gel-filled mammary implant which consists of a conventional silica-containing silicone elastomer implant shell containing an outer coating of a filler-free silicone polymer is described.
  • the stated purpose for the outer coating is "to provide a shield barrier between body tissue, and the silica containing silicone elastomer implant shell" (Data Sheet, p. 1). No mention is made concerning the problem of surface-bleed when the gel is a silicone gel.
  • a silicone gel-filled silicone rubber article possessing a reduced tendency to exhibit surface-bleed comprising (A) a flexible silicone rubber container filled with (B) a silicone gel composition, there being (C) an essentially continuous barrier layer of a composition consisting essentially of a fluorine-containing organopolysiloxane situated between the interior of container (A) and the gel of (B).
  • the composition (C) contains a sufficient amount of a fluorine-containing organopolysiloxane which is sufficiently incompatible with the components found in gel (B) to retard the passage of migratable gel components into the container (A) and thereby reduce the amount of bleed appearing on the surface of (A).
  • the invention relates to a flexible silicone gel-filled silicone rubber article possessing a reduced tendency to exhibit surface-bleed consisting essentially of a flexible fluorosilicone rubber container filled with a silicone gel composition.
  • Figure 1 is a perspective view of a surgically implantable prosthesis shaped to supplement a female breast, constructed in accordance with the teachings of the present invention
  • Figure 2 depicts a cross-section on a vertical median of the prosthesis of Figure 1.
  • the present invention relates to a silicone gel-filled silicone rubber article possessing a reduced tendency to exhibit surface-bleed comprising:
  • the present invention also relates to a silicone gel-filled silicone rubber article possessing a reduced tendency to exhibit surface-bleed consisting essentially of
  • Figure 1 shows one embodiment of the present invention shown as P which is a surgically implantable prosthesis shaped to replace a female breast-and constructed in accordance with the present invention.
  • the outside container is shown as 21.
  • Other types of embodiments will be readily apparent to those skilled in the art because the basic construction can be altered to assume the particular shape required.
  • an external breast prosthesis designed for use within a brassiere cup would have a similar shape.
  • the actual shape of the article does not form a part of the present invention and the shape shown is solely for the purpose of illustration.
  • the article of the present invention comprises three main parts: a flexible silicone rubber container 21, a silicone g el composition filler material 23 located within the container and an essentially continuous barrier layer 22 situated between container 21 and gel composition 23.
  • the principal requirement of the present invention is that the barrier layer 22 be an essentially continuous coating covering the entire inside wall area of container 21. Uniformity of coating thickness is generally not critical as long as the coating is essentially continuous.
  • the term "essentially" continuous is meant to indicate that the presence of a small amount of pinholes or other small areas of surface coating defects can be tolerated, although it is preferred that no such defects be present.
  • the silicone rubber container 21 is based on a gum which has been cross-linked or to use other commonly accepted terms, "vulcanized” or “cured".
  • the gum is principally composed of a polydimethylsiloxane.
  • polydimethylsiloxane it is to be understood that the majority of the siloxane units present in the gum are dimethylsiloxane units, but that minor amounts of other diorganosiloxane units can be present such as methylvinylsiloxane units, methylphenylsiloxane units and diphenylsiloxane units.
  • the gum can also contain minor amounts of monoorganosiloxane units and Si0 2 units which provide branching.
  • Thegums can be endblocked by conventional endblocking units such as triorganosiloxy units such as dimethylvinylsiloxy units, trimethylsiloxy units or methylphenylvinylsiloxy units or by hydroxyl radicals. Since these gums are well-known to those skilled in the art, no further elaboration is necessary.
  • silicone gel-filled silicone rubber articles exhibit surface-bleed is dependent upon the composition of the gel and the composition of the container.
  • the silicone rubber container is essentially composed of a cross-linked polydimethylsiloxane and the silicone gel composition is essentially composed of polydimethylsiloxane components.
  • the gel composition is kept the same and methylphenylsiloxane units are substituted for a portion of the dimethylsiloxane siloxane units in the silicone rubber container, as the mole percentage of methylphenylsiloxane units is increased, the tendency for the unreacted components present in the gel composition to bleed through the container walls will decrease, although the difference may not be apparent until a large percentage of the container is composed of methylphenylsiloxane units.
  • the container material is kept constant and the silicone gel composition is varied as above.
  • silicone rubber containers formed from gums which are essentially composed of polydimethylsiloxane.
  • the flexible container 21 of Figure 2 can be manufactured from a fluorosilicone rubber consisting essentially of fluoroalkylpolysiloxane in which case there is no need for the presence of a barrier layer 22 in the article because the container itself can function as the barrier layer.
  • the fluoroalkylpolysiloxanes are described infra and the preferred gum is 3,3,3-trifluoropropylmethylpolysiloxane.
  • the fluorosilicone rubber can also contain fillers, additives and the like.
  • Silicone rubbers are well known and can contain fillers, such as reinforcing silica filler; processing aids, additives, and pigments such as titanium dioxide.
  • the silicone rubber can be cross-linked or vulcanized by conventional means such as with organic peroxides, electromagnetic radiation or by using a polysiloxane cross-linker containing silicon-bonded hydrogen atoms with a vinyl-containing gum and a platinum catalyst.
  • the proportions of these ingredients are well known in the art and those skilled in the silicone rubber art can readily adjust the ingredients and proportions to provide a silicone rubber which will suit their particular desires in physical properties for the container.
  • the container wall should be sufficiently soft and flexible so as to simulate a natural appearance and feel.
  • such containers are about 0.25 mD in average thickness.
  • the silicone gel filling material shown as 23 in Figure 2, is a composition which consists essentially of a silicone gel of cross-linked polydimethylsiloxane, which composition can also include unreacted polyorganosiloxane fluids, additives, pigments, processing aids and the like.
  • cross-linked polydimethylsiloxane it is to be understood that the majority of the siloxane units present in the cross-linked gel portion of the gel composition are dimethylsiloxane units although lesser amounts of other diorganosiloxane units such as methylphenylsiloxane units may also be present.
  • Silicone gel compositions suitable for use in the articles of the present invention are well known in the art.
  • Silicone gel compositions are described by Cronin in U.S. Patent No. 3,293,663 issued December 27, 1966 (hereinafter referred to as Cronin), which refers to a specific type of the gels described by Nelson in U.S. Patent No. 3,020,260 issued February 6, 1962 (hereinafter referred to as Nelson).
  • Brill in U.S. Patent No. 4,100,627 issued July 18, 1978 describes another type of silicone gel.
  • the Cronin, Nelson and Brill patents are hereby incorporated by reference to teach various types of silicone gel compositions which can be used in the articles of the present invention, methods for the production of such gels, penetration values useful for mammary prostheses and methods for determining the penetration values of such gels.
  • the barrier layer 22 forms the basis for the reduced tendency of the silicone gel-filled silicone rubber articles described herein to exhibit surface-bleed. While not intending to limit the present invention by the following theoretical discussion, it is believed that some discussion of the reasoning behind the use of the barrier layer 22 will aid others in the utilization of these articles.
  • the barrier layer 22 is an essentially continuous barrier layer of a filler-containing composition comprising a fluorine-containing organopolysiloxane. Fluorine-containing organopolysiloxanes tend to be more or less chemically incompatible with organopolysiloxanes which do not contain fluorine such as polydimethylsiloxane fluids.
  • the composition of the barrier layer must be such that it presents an incompatible layer of a sufficient thickness to contain the components of the silicone gel 23 which would normally tend to migrate through the silicone rubber container 21 in the absence of a barrier layer and as a result, render the surface of the container oily.
  • Fluorine-containing organopolysiloxanes useful in the barrier layer 22 of the present invention can be those which are sufficiently incompatible with the components of the silicone gel so as to inhibit their migration to the silicone container 21, are capable of being used in a composition which forms an essentially continuous barrier layer on the interior of container 21, and, especially when utilized in surgically implantable prostheses, are sufficiently inert with respect to the human body to be useful in such articles.
  • the fluorine-containing organopolysiloxanes used in the barrier layer composition can be selected from fluoroalkylpolysiloxanes such as those described in U.S. Patent Nos. 2,961,425 issued November 22, 1960 to Pierce et al.; 3,002,951 issued October 3, 1961 to Johannson; 3,006,878 issued October 31, 1961 to Talcott; 3,179,619 issued April 20, 1965 to Brown and 3,697,473 issued October 10, 1972 'to Polmanteer et al. which are referred to to show the types of fluoroalkylpolysiloxanes which can find use as the barrier layer 22 and to show methods for the preparation of such fluoroalkylpolysiloxanes.
  • fluoroalkylpolysiloxanes can be described as being principally composed of siloxane units of the formula (RCH 2 CH 2 )R'SiO where R is a perfluoroalkyl radical of less than 11 carbon atoms such as CF 3 -, C 2 F 5 -, C 3 F 7 - and C 10 F 21 - and can be either straight chain or branched chain radicals while R' is an alkyl radical of 1 to 3 inclusive carbon atoms such as methyl, ethyl, propyl, or isopropyl.
  • R is a perfluoroalkyl radical of less than 11 carbon atoms such as CF 3 -, C 2 F 5 -, C 3 F 7 - and C 10 F 21 - and can be either straight chain or branched chain radicals while R' is an alkyl radical of 1 to 3 inclusive carbon atoms such as methyl, ethyl, propyl, or isopropyl.
  • Hydroxyl-endblocked homopolymers consisting almost entirely of (RCH 2 CH 2 )R'SiO units (it being recognized that small amounts of mono-substituted, trisubstituted or Si0 2 siloxane units can be present due to by-products present during manufacture) can be utilized.
  • R x SiO 4-x siloxane units enables 2
  • one to select various means for cross-linking these fluoroalkylpolysiloxanes and examples of these siloxane units include the following units: (CH 3 )(C 2 H 4 )SiO, (CH 3 ) 2 SiO, (CH 3 )(C 2 H 4 )(C 6 H 5 )SiO 0.5 , (CH 3 ) 3 SiO 0.5 , CH 3 SiO l . 5 and (CH 3 )(C 2 H 5 ) 2 SiO O . 5 .
  • Larger amounts of R" x SiO 4-x units 2 can be used in such copolymers, but the ability of a barrier layer to reduce bleed is expected to decrease as the amount of nonfluorine-containing siloxane units is increased beyond 10 mole percent.
  • the preferred type of fluoroalkylpolysiloxane to use as the barrier layer 22 are those which are principally composed of ⁇ (CF 3 CH 2 CH 2 )(CH 3 )SiO ⁇ siloxane units, and contain less than 10 mole percent of R" x SiO 4-x 2 siloxane units where each R" is a methyl of vinyl radical, there being no more than one vinyl radical per siloxane unit (hereinafter referred to as 3,3,3-trifluoropropyl- methylpolysiloxanes).
  • the 3,3,3-trifluoropropylmethylpolysiloxane is a gum which is capable of being cross-linked by means of a platinum catalyst method.
  • a gum is generally defined to be a polydiorganosiloxane with a viscosity of over 1 meter 2 per second (1,000,000 centistokes) and is usually described in terms of its Williams plasticity which is described in ASTM D926.
  • barrier-layer compositions exhibited poor coating or wet-out properties on the silicone rubber container in the absence of a filler.
  • Low viscosity trimethylsiloxy-endblocked 3,3,3-trifluoropropylmethylpolysiloxane fluids having a viscosity of about 300 centistokes (0.3 Pa.s (pascal seconds)) and high molecular weight 3,3,3-trifluoropropylmethylpolysiloxane gum dispersions in acetone were evaluated by injecting the fluid or dispersion into a reinforcing silica filler-containing silicone rubber container consisting primarily of cross-linked polydimethylsiloxane and observing the coating formed on the inside of the container.
  • the barrier layer composition can contain small amounts of various additives such as plasticizers, colorants, dyes or compounds and/or polymers used to cross-link or cure the fluorine-containing organopolysiloxane.
  • various additives such as plasticizers, colorants, dyes or compounds and/or polymers used to cross-link or cure the fluorine-containing organopolysiloxane.
  • Cross-linking can be accomplished by any of a number of well-known means such as by peroxides, radiation, and silanol condensation reactions catalyzed by metal carboxylic acid salts.
  • Room temperature vulcanization of fluorine-containing compositions is taught in U.S. Patent No. 3,624,022 issued November 30, 1971 to Ross (silane additive plus a metal salt of a carboxylic acid) and in U.S. Patent No. 3,077,465 issued February 12, 1963 to Bruner (moisture-curable acetoxy-endblocked polyorganosiloxane).
  • the preferred method for cross-linking the fluorine-containing organopolysiloxane in the barrier-layer composition is by means of a platinum-catalyzed reaction between siloxane units containing hydrogen bonded directly to a silicon atom and siloxane units containing unsaturated alkyl radicals bonded to silicon atoms by means of a carbon-silicon bond such as vinyl radicals.
  • the means for accomplishing platinum catalyzed cross-linking of fluorine-containing polydiorganosiloxanes is set out in the literature such as in U.S. Patent No. 3,697,473 issued October 10, 1972 to Polmanteer, et al. and U.S. Patent No.
  • the barrier layer compositions are preferably applied as dispersions in polar organic solvents such as ketones such as acetone and methyl isobutyl ketone, esters or chlorinated hydrocarbons such as 1,1,1-trichloroethane.
  • polar organic solvents such as ketones such as acetone and methyl isobutyl ketone, esters or chlorinated hydrocarbons such as 1,1,1-trichloroethane.
  • the solvent of choice for the dispersions containing 3,3,3-trifluoropropylmethylpolysiloxane gums was acetone.
  • viscosity approximately 3000 centipoise (3 Pa ⁇ s) some coating problems were encountered when the container and barrier layer were produced by the dipping process hereinafter described.
  • the silicone rubber containers are pre-formed and the barrier-layer composition is applied by injecting a dispersion of the same into the container as described infra, adequate barrier-layer coatings can be obtained upon curing such compositions.
  • the container 21 can be formed by conventional means such as by vacuum-forming or by dip-coating a mandrel of the desired size into a solution or dispersion of a composition which will then be cured such as by heating to form the flexible silicone rubber container.
  • the container 21 is stripped from the mandrel leaving a small opening which can be sealed by means of a patch made from the same type of silicone rubber material as is the container and a drop of high strength silicone elastomer can be used to adhere the patch to the container.
  • the patch itself can be unvulcanized and simply placed over the hole to be vulcanized or cured at a later time.
  • the inside of the container is then coated by first inserting a hypodermic needle through the wall of the container and introducing a sufficient amount of air into the container to produce a wrinkle-free surface which can be evenly coated with the barrier-layer composition.
  • the barrier-layer composition is then introduced through the hypodermic needle, typically as a solvent dispersion, the needle hole is sealed and the containers are tumbled in a rotating drum to evenly coat the interior of the container.
  • heat can be introduced to form a cured barrier layer.
  • Uncured silicone gel composition is then introduced by means of a hypodermic needle and the silicone gel is cured such as by heating the article. It may be possible to introduce a cured silicone gel directly into the container if the gel is capable of passing through the injecting means.
  • Another method for preparing the silicone gel-filled silicone rubber articles of the present invention consists of using a conventional dip-coating technique which comprises first dip-coating a mandrel of the proper shape to form a coating of the uncured silicone rubber container material and then dip-coating that coated mandrel in a solution of dispersion of the uncured barrier-layer composition.
  • This method is preferred over the previously described method when dispersions containing non-flammable solvents are used or where adequate provision for maintaining dipping tanks of flammable solvents is available because the process is more commercially efficient.
  • the coatings on the mandrel are then cured to form a container with a cured barrier layer.
  • the container is then stripped from the mandrel, leaving a small hole which is sealed.
  • the container is stripped from the mandrel, it is turned inside out resulting in a container having a barrier layer on the interior wall.
  • the shape of the mandrel can be either circular or ellipsodial depending upon the desired container shape while the size is dictated by the container volume desired. Such mandrels and procedures for their use are well known in the art.
  • the uncured silicone gel composition is then injected and cured (or cured silicone gel may be injected) to form a silicone gel-filled silicone rubber article with a reduced tendency to exhibit surface-bleed.
  • the barrier layer could comprise a reinforcing silica filled fluorine-containing organopolysiloxane composition coating on the outside of the silicone rubber container and some reduction in bleed could be observed, the preferred procedure is to use a barrier layer on the inside of the container wall to reduce the amount of gel components reaching the silicone rubber container.
  • the silicone gel-filled silicone rubber article described above is directed towards an article with reduced tendency to exhibit surface-bleed and that the physical shape of the article can be altered without affecting the reduced-bleed characteristics provided that the barrier layer is essentially continuous.
  • various types of modifications to the outside of the gel-filled articles described herein may be made without affecting the reduced-bleed characteristics.
  • a layer of porous material can be attached to the outside of the article to enable body tissue to grow into such porous material and anchor the prosthesis to the chest wall (see Cronin cited above).
  • the articles can have appendages which are designed to properly fit a brassiere and such prostheses can also contain pigments and colorants to produce a natural, flesh-tone appearance.
  • the preferred embodiment of the present invention is a silicone gel-filled silicone rubber article with a reduced tendency to exhibit surface-bleed and is shaped in the form of either an external mammary prosthesis or a surgically implantable article, especially one which is useful as an implantable mammary prosthesis.
  • These preferred prostheses comprise a flexible silicone rubber container 21 which consists essentially of a cross-linked gum essentially composed of polydimethylsiloxane; a silicone gel composition 23 filling material which consists essentially of a gel which is a cross-linked essentially polydimethylsiloxane wherein any additives present in the gel which contain siloxane units have methyl radicals as the majority of the substituents attached to silicon atoms by means of carbon-silicon bonds and a barrier layer 22 which is a filler-containing composition consisting essentially of a cross-linked gum consisting essentially of 3,3,3-trifluoropropylmethylsiloxane.
  • the container 21, the silicone gel 23 and the barrier layer 22 are each cross-linked by means of a platinum catalyst to avoid the possibility of platinum catalyst poisoning due to the presence of residual amounts of another type of curing agent, such as a peroxide, which could be present if, for example, the container was peroxide-cured.
  • a platinum catalyst to avoid the possibility of platinum catalyst poisoning due to the presence of residual amounts of another type of curing agent, such as a peroxide, which could be present if, for example, the container was peroxide-cured.
  • Method I involved preparing the gel-filled articles, cleansing the surface with isopropanol and drying the articles to be tested. Each sample was placed in a circular covered glass tissue culture dish (60 mm in diameter by 15 mm high which are sometimes referred to as "Petri" dishes) between two pieces of white laboratory filter paper 5.5 centimeters (cm) in diameter. The sample containing dishes were stacked in layers between 10 cm x 15 cm x 0.16 cm aluminum plates--four dishes per layer with the top layer having three dishes and a weight at the very top--and the stack was stored at ambient temperature.
  • Method II involved weighing the paper on which the silicone gel-filled article was to be stored with an analytical balance and recording the increase in weight of the paper as a function of time, said increase being attributed to material exuding or bleeding through the container walls.
  • Dispersion B was a 10% solids dispersion prepared by adding 100 grams of Dispersion A to 40.3 grams of 1,1,1-trichloroethane and mixing well.
  • Dispersion C was prepared using the following gum base (Base 2) which consisted of 100 parts of a hydroxy-endblocked polydiorganosiloxane gum which contained 3,3,3-trifluoropropylmethylsiloxane units and about 0.6 mole percent of methylvinylsiloxane units and had a plasticity of 137 mils (3.48 mm), 1.9 parts of a hydroxy-endblocked polydiorganosiloxane gum which contained dimethylsiloxane units and about 4 mole percent of methylvinylsiloxane units and had a plasticity in the range of 50-70 mils (1.27-1.78 mm), 6 parts of a hydroxy-endblocked polydimethylsiloxane fluid having about 4 weight percent silicon-bonded hydroxyl radicals and having a viscosity of about 4 x 10- 5 meters 2 per second (m 2 /s) at 25°C, and 21 parts of a reinforcing fume silica filler
  • Polymer 2 was a trimethylsiloxy-endblocked polyorganosiloxane having about 46 mole percent of 3,3,3-trifluoropropylmethylsiloxane units and about 54 mole percent of methylhydrogensiloxane units where the mole percent is exclusive of the trimethylsiloxy units and having a silicon-bonded hydrogen atom content in the range of 0.4 to 0.5 weight percent.
  • Dispersion C contained about 20% solids.
  • Dispersion D contained about 11% solids and was prepared in the same manner as was Dispersion C using 80 grams of acetone, 10 grams of Base 2, 0.08 grams of Catalyst 2, 0.04 grams of 2-methyl-3-butyn-2-ol and 0.15 grams of Polymer 2.
  • a stainless steel youth size testicular envelope mandrel 2.4 cm x 3.4 cm long which was capable of producing a container with a fill volume of 9.4 cubic centimeters was used to produce the containers used in these examples.
  • the mandrel was attached to a 0.48 cm rod to produce a handle for dipping the mandrel.
  • the rod was then attached to an electric motor drive dipping apparatus which was adjusted to allow the mandrel to be raised or lowered at a constant rate.
  • the mandrel was cleaned with solvent and slowly inserted into a container filled with the dispersion being used. The mandrel was then removed at the rate of 2 inches per minute. As soon as the mandrel was free from the surface, the mandrel was inverted and allowed to dry with the handle side down for at least five minutes time between dips. After the final coating was applied, the coated mandrel was allowed to dry for at least 10 minutes prior to placing it in an oven in an inverted position. Table I details the number of dips and the dispersions used in each dip. The following heating schedule was used to cure the coatings on the mandrels: Example 1 - 60 minutes at 150°C; Examples 2 and 3 - 60 minutes at 175°C and Examples 4-9 - 30 minutes at 175°C.
  • the mandrel was cooled under a tap water stream and dried.
  • a standard No. 3 size cork borer was slipped over the handle to cut a hole through the top of the container.
  • the cured container was then dusted with sodium bicarbonate to facilitate removal from the mandrel which removal was accomplished by rolling the envelope off the mandrel starting at the hole cut through the top.
  • the container was turned inside out when the container was removed from the mandrel and the last layer to be coated became the inner layer.
  • the thickness of the top (where the hole was made), the bottom and an average thickness was measured and is shown in Table I as is the composition of the envelope in number of dips starting from the inside layer outward.
  • the hole-patching procedure used in this bleed study was to impregnate 100 parts of Base 2 with 3 parts of a 50% active paste of 2,4-dichlorobenzoyl peroxide (CadoxD TS-50, a product of the Noury Chemical Company, Burt, NY 14028) on a roller mill, press a sample between two pieces of polyethylene coated paper to produce a sheet of unvulcanized gum base, remove one sheet of paper and place a piece of polyethylene terephthalate fabric between the gum base and the paper. The sheet was placed in a hydraulic press for about 15 minutes at a pressure of greater than 1.6 x 10 8 pascals to produce a sheet of about 0.38-0.51 mm in thickness.
  • CadoxD TS-50 2,4-dichlorobenzoyl peroxide
  • the containers were than washed in hot tap water and dried in an oven for 15 minutes at 150 C.
  • a patch was cut from above using a standard size No. 7 cork borer and the paper was removed from the side opposite the fabric. This type of patch was then placed over the outside of the hole in each envelope except for Example 1, which was covered with a patch made from an unvulcanized polydimethylsiloxane gum base, and the patched envelopes were placed in an oven for 15 minutes at 150°C to vulcanize the patch material. All the patches had good adhesion to the envelopes.
  • a double layer patch can be used.
  • a patch composed of an unvulcanized fluorine-containing polyorganosiloxane gum base which is slightly larger than the hole can be centered on a slightly larger patch composed of an unvulcanized polydimethylsiloxane gum base and the double-layered patch is then placed over the outside of the hole.
  • the hole can also be patched from the inside by reversing the order of the layers such that the silicone gel-containing composition is only in contact with the barrier layer portion of the patch.
  • the patched containers were each filled with 8.00 + 0.25 grams of an uncured silicone gel composition by means of a 15 gauge hypodermic needle inserted directly through the container wall.
  • the filled envelopes were washed with isopropanol after filling, air bubbles were removed and the filled containers were placed in an oven for three and one-half hours at 160°C to form the silicone gel.
  • the cured silicone gel composition consisted of a uniform composition suitable for use in a mammary prosthesis containing about 80% by weight of unreacted trimethylsiloxy-endblocked polydimethylsiloxane fluid having a viscosity in the range of 0.00095 to 0.00105 m 2 /s at 25°C and about 20% of a cross-linked silicone gel consisting essentially of polydimethylsiloxane of the type described in the Nelson Patent.
  • the cured gel composition had a penetration value of 30.0 mm. The penetration value was determined according to the procedure taught in the Cronin Patent.
  • the gel composition was rather soft, the following head and rod was used in place of the brass head and shaft described in Cronin--Head-an aluminum shaft about 15 cm long by 0.31 cm in diameter which was fitted with an aluminum tip 0.31 cm long and 2.54 + 0.02 cm in diameter (weight 7.5 g) and rod-a magnesium rod 21.6 cm long by 0.48 cm in diameter (weight 7.1 g).
  • the head is mounted on the end of the rod.
  • This gel contains unreacted fluids which are known to bleed through silicone rubber containers.
  • the cumulative rating reported in Table II corresponds to the sum total of the values assigned to the degree of paper spotting observed at each interval.
  • the numerical rating values assigned to each degree of spotting is shown at the bottom of Table II. Also taken into account were factors such as whether the spot was on the top or bottom and whether the spot covered less than the total area covered by the article.
  • a cumulative rating value of zero indicated the least amount of bleed while higher values indicated a higher tendency to exhibit visual evidence of bleed.
  • Dispersion E was prepared by blending 100 parts of a different batch of Base 2 with 10 parts of a silicone fluid slurry containing approximately 62 percent by weight of titanium dioxide pigment (this material is sold under the tradename of Ferro White GV-52 by the Ferro Corporation, Cleveland, Ohio) on a 2-roll mill. Then 10 parts of this blend was added to a jar containing 90 parts of acetone and the contents of the jar was rolled overnight to completely disperse the blend.
  • the containers had a wall thickness of approximately 0.25 mm and were produced by curing a platinum catalyzed dispersion similar to Dispersion A on a mandrel.
  • the general procedure used to coat the containers was to inject 30 cubic centimeters (cc) of Dispersion E into the Size X (225 cc volume) envelopes and 50 cc of Dispersion E into the larger Size Y (340 cc volume) containers using an 18 gauge hypodermic needle inserted directly through the container wall. Before removing the needle, a sufficient amount of air was injected into each container to remove all wrinkles. The needle was removed and a patch of unvulcanized polydimethylsiloxane gum base was placed over the needle hole. Each container was lightly powdered and placed into a gallon can (one container per can) which had holes punched in the ends to allow volatile solvent to escape.
  • Example 11 and 12 were cured by heating the containers in an oven 30 minutes at 50°C and then for one hour at 175°C.
  • the coatings in Examples 10, 16, 17 and 18 were cured by heating the containers in an oven for 15 minutes at 50°C and then for one hour at 175°C.
  • Examples 13-15 and 19-21 are comparative examples and did not contain a barrier layer.
  • Each Size X container was injected with 194 grams (330 grams for each Size Y container) of the same type of uncured silicone gel composition as was used in the previous Examples.
  • the uncured silicone gel composition contained a mole ratio of silicon-bonded hydrogen atoms to silicon-bonded vinyl groups of 1/1.9 and when cured had a penetration value of 17.0 cm.
  • the bleed evaluation was done by first placing a disk of polytetrafluorethylene sheet in the bottom of a laboratory beaker, followed by four sheets of laboratory filter paper on top of the disk and finally placing one container filled with the silicone gel composition on top of the filter paper. All of the beakers containing the articles were then placed in the same oven for three and one-half hours to cure the gel composition. Upon cooling to room temperature, the silicone gel-filled article was carefully removed, the filter paper and disk weighed on an analytical balance to the nearest 0.001 gram and replaced in the beaker in the same order as done previously to insure that the same part of the article was in contact with the filter paper as before.
  • the polytetrafluoroethylene disk is used to prevent loss of any fluid absorbed by the filter paper.
  • This example describes an optimized formulation for use in coating pre-formed silicone rubber containers with a barrier layer.
  • the barrier layer composition was prepared by mixing 100 parts of a gum base having the same general composition as Base 2 and 10 parts of the same type of titanium dioxide slurry used in the previous examples on a 2-roll mill. Then 80 grams of the milled.mixture was cut into small pieces and added to 320 grams of dried acetone. The jar containing the acetone and milled mixture was capped and the milled mixture was completely dispersed by rolling the jar for several hours. When the contents of the jar were completely dispersed, 0.08 grams of Catalyst 1 and 0.16 grams of 1-ethynylcyclohexanol was added to the above dispersion and mixed well. Then 1.6 grams of Polymer 1 was addeu. The dispersion was thoroughly stirred and used.
  • This example demonstrates the reduced tendency to exhibit surface-bleed possessed by a silicone rubber article wherein the container consists essentially of a cross-linked 3,3,3-trifluoropropylmethylpolysiloxane gum containing a silica filler.
  • the gum base formulation used in preparing the container consisted of the following: 100 parts of a dimethylvinylsiloxy-endblocked polydiorganosiloxane g um of the same type used to prepare Base 1; 42 parts of a fume silica filler having an average pore volume of about 400 m 2 /g; 18 parts of Fluid 1; 0.5 parts of Fluid 2 and 1 part of ammonium bicarbonate.
  • Fluid 1 was a hydroxy-endblocked 3,3,3-trifluoropropylmethylpolysiloxane fluid having a silicon-bonded hydroxyl radical content in the range of 5.2 to 7.0 weight percent and a viscosity in the range of from 0.00007 to 0.00013 m 2 /s.
  • Fluid 2 was a hydroxy-endblocked polydiorganosiloxane fluid containing dimethylsiloxane units and a sufficient amount of methylvinylsiloxane units to provide from 9 to 12 weight percent of silicon-bonded vinyl radicals, said fluid containing at least 8 weight percent of silicon-bonded hydroxyl radicals and having a viscosity in the range of from 0.00002 to 0.00006 m 2 /s.
  • the gum base was prepared by mixing the above gum, 13 parts of Fluid 1 and 0.25 parts of Fluid 2 in a bread dough mixer, then adding the silica filler as rapidly as possible and allowing it to become thoroughly blended. The remainder of Fluids 1 and 2 were added, the mixture was cooled and the ammonium bicarbonate was added. Mixing was continued for another 30 minutes under vacuum without any additional heating. Then, mixing was continued as the mixture was heated to 170°C and maintained at that temperature for 3 hours. It was then cooled for one hour and used.
  • Dispersion F was prepared by dispersing 0.5 grams (g) of zinc stearate into 100 g of the above gum base on a 2-roll mill. This material was then dispersed in 400 g of methyl isobutyl ketone. Prior to use, 3 drops (about 0.05 g) of a type Catalyst 2 (see Examples 1-9) solution (this catalyst solution was neutralized with a small amount of sodium bicarbonate to remove any residual hydrogen chloride generated during manufacture) and 1.3 g of a composition consisting principally of a compound having an average formula CF 3 CH 2 CH 2 Si(OSi(CH 3 ) 2 H) 3 , (a minor amount of dimeric species was also present) having a silicon-bonded hydrogen content in the range of about 0.5 to 0.7 weight percent was added to the above.
  • a 225 cc volume container was produced by dipping a mandrel in Dispersion F for 30 seconds, removing the mandrel and allowing the coated mandrel to air-dry for fifteen minutes. This procedure was repeated three times. After the last dip, the coated mandrel was allowed to air-dry for one hour and was then placed in an oven for four hours at 160°C.
  • Example 1-9 Following the same procedures outlined in Example 1-9, the cured container was then removed from the mandrel, patched, filled with a silicone gel composition of the same type used in Examples 1-9 and the gel composition was cured.
  • the procedure used to evaluate the tendency to exhibit bleed is described in U.S. Patent No. 4,100,627, column 6, lines 19-47 which paragraph is hereby incorporated by reference to teach that procedure.
  • the total amount of bleed observed according to this test was 0.0594 g.
  • Another similar article exhibited 0.1381 g of bleed after two months time although a pinhole in the container wall appeared to account for the larger amount of bleed observed in the latter.
  • a comparable article manufactured from a silicone rubber container of the type used in Example 13 exhibited a total of 0.27 grams of bleed after two months storage at room temperature.

Landscapes

  • Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Materials For Medical Uses (AREA)
  • Laminated Bodies (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
EP19800304431 1979-12-17 1980-12-09 Article en caoutchouc de silicone rempli d'un gel de silicone avec exsudation réduite Expired EP0030838B1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10448079A 1979-12-17 1979-12-17
US104480 1979-12-17

Publications (2)

Publication Number Publication Date
EP0030838A1 true EP0030838A1 (fr) 1981-06-24
EP0030838B1 EP0030838B1 (fr) 1984-03-07

Family

ID=22300723

Family Applications (1)

Application Number Title Priority Date Filing Date
EP19800304431 Expired EP0030838B1 (fr) 1979-12-17 1980-12-09 Article en caoutchouc de silicone rempli d'un gel de silicone avec exsudation réduite

Country Status (5)

Country Link
EP (1) EP0030838B1 (fr)
JP (1) JPS6110137B2 (fr)
BR (1) BR8008981A (fr)
CA (1) CA1199451A (fr)
WO (1) WO1981001650A1 (fr)

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4472226A (en) * 1979-10-03 1984-09-18 Minnesota Mining And Manufacturing Company Silicone gel filled prosthesis
EP0174141A1 (fr) * 1984-08-30 1986-03-12 Daniel Brauman Dispositif de prothèse implantable
FR2619706A1 (fr) * 1987-09-02 1989-03-03 Chachques Juan Carlos Dispositif chirurgicalement implantable pour la formation d'un neo-ventricule
EP0318193A2 (fr) * 1987-11-25 1989-05-31 Dow Corning Wright Corporation Méthodes de fabrication de réservoirs gonflables implantables en silicone
WO1996003940A1 (fr) * 1994-08-05 1996-02-15 Innovative Technologies Limited Protheses mammaires
EP0904088A1 (fr) * 1996-10-18 1999-03-31 Life Medical Sciences, Inc. Coussin de silicone rempli de gaz ou de gel pour traiter les cheloides et les cicatrices hypertrophiques
WO2006137695A1 (fr) * 2005-06-22 2006-12-28 Korea Institute Of Machinery And Materials Bruleur destine a la regeneration de filtre contre les matieres en suspension d’un moteur diesel
WO2009018105A1 (fr) * 2007-07-27 2009-02-05 Allergan, Inc. Prothèse mammaire remplie de gel élastomère formant barrière
WO2010045581A1 (fr) * 2008-10-17 2010-04-22 Allergan, Inc. Enveloppe d'implant prothétique
WO2010045579A2 (fr) * 2008-10-17 2010-04-22 Allergan, Inc. Enveloppe d'implant prothétique
WO2011022235A3 (fr) * 2009-08-18 2011-06-16 Allergan, Inc. Implant prothétique renforcé avec enveloppe souple

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4778467A (en) * 1984-04-25 1988-10-18 The University Of Utah Prostheses and methods for promoting nerve regeneration and for inhibiting the formation of neuromas
JPS6135635U (ja) * 1984-08-03 1986-03-05 敬子 亀田 食品用容器
JPH0445658Y2 (fr) * 1986-06-13 1992-10-27
JPS63117444U (fr) * 1987-01-22 1988-07-29
JPS63147125U (fr) * 1987-03-17 1988-09-28
JPH01135527A (ja) * 1987-11-24 1989-05-29 Shinya Takada 水蒸気発生体およびその製造法
JPH02161919A (ja) * 1987-12-10 1990-06-21 Erugu:Kk 加熱装置
US4992312A (en) * 1989-03-13 1991-02-12 Dow Corning Wright Corporation Methods of forming permeation-resistant, silicone elastomer-containing composite laminates and devices produced thereby
JPH02127182U (fr) * 1989-03-28 1990-10-19
US5370688A (en) * 1993-03-30 1994-12-06 Spenco Medical Corporation Encapsulated gel breast prosthesis and method of making
EP2619249B1 (fr) * 2010-09-22 2014-05-14 Dow Corning Corporation Compositions à haut indice de réfraction contenant des copolymères à blocs résine d'organosiloxane - organosiloxane linéaire
JPWO2022172930A1 (fr) * 2021-02-09 2022-08-18

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3366975A (en) * 1965-06-04 1968-02-06 William J. Pangman Compound prosthesis
US3559214A (en) * 1968-10-17 1971-02-02 William J Pangman Compound prosthesis
US3683424A (en) * 1970-01-30 1972-08-15 William J Pangman Surgically implantable compound breast prosthesis
US3688318A (en) * 1970-09-17 1972-09-05 Introspec Inc Methods and articles for preventing clotting of blood
DE1669883B2 (de) * 1965-03-19 1974-02-28 Dow Corning Corp., Midland, Mich. (V.St.A.) Beschichten von Formkörpern aus Organopolysiloxanelastomeren für den medizinischen Gebrauch
DE2711383B2 (de) * 1976-05-27 1978-12-21 Dow Corning Corp., Midland, Mich. (V.St.A.) Polysiloxangele und deren Verwendung
WO1980002107A1 (fr) * 1979-04-09 1980-10-16 H Anderl Materiau pour prothese

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3179619A (en) * 1965-04-20 Xow swell, high temperature organosi- loxane rubbeks containing silicon- bonded fluokjnated aliphatic radicals
US3020260A (en) * 1960-08-18 1962-02-06 Dow Corning Organosiloxane potting compound
US3279996A (en) * 1962-08-28 1966-10-18 Jr David M Long Polysiloxane carrier for controlled release of drugs and other agents
US3293663A (en) * 1963-08-12 1966-12-27 Dow Corning Surgically implantable human breast prosthesis
US3665520A (en) * 1970-10-07 1972-05-30 Medical Eng Corp Surgically implantable breast prosthesis
US3911503A (en) * 1974-01-21 1975-10-14 George Hankin Breast prosthesis
US3896506A (en) * 1974-01-21 1975-07-29 George Hankin Breast prosthesis
US3902198A (en) * 1974-05-20 1975-09-02 Gore & Ass Method of replacing a body part with expanded porous polytetrafluoroethylene
US4100627A (en) * 1976-05-27 1978-07-18 Dow Corning Corporation Low oiling gel filled flexible articles and gels therefor
US4172298A (en) * 1976-06-16 1979-10-30 Cornelius Rechenberg Breast prosthesis
US4199825A (en) * 1976-10-12 1980-04-29 Bodo Knoche Breast prosthesis

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1669883B2 (de) * 1965-03-19 1974-02-28 Dow Corning Corp., Midland, Mich. (V.St.A.) Beschichten von Formkörpern aus Organopolysiloxanelastomeren für den medizinischen Gebrauch
US3366975A (en) * 1965-06-04 1968-02-06 William J. Pangman Compound prosthesis
US3559214A (en) * 1968-10-17 1971-02-02 William J Pangman Compound prosthesis
US3683424A (en) * 1970-01-30 1972-08-15 William J Pangman Surgically implantable compound breast prosthesis
US3688318A (en) * 1970-09-17 1972-09-05 Introspec Inc Methods and articles for preventing clotting of blood
DE2711383B2 (de) * 1976-05-27 1978-12-21 Dow Corning Corp., Midland, Mich. (V.St.A.) Polysiloxangele und deren Verwendung
WO1980002107A1 (fr) * 1979-04-09 1980-10-16 H Anderl Materiau pour prothese

Cited By (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4472226A (en) * 1979-10-03 1984-09-18 Minnesota Mining And Manufacturing Company Silicone gel filled prosthesis
EP0174141A1 (fr) * 1984-08-30 1986-03-12 Daniel Brauman Dispositif de prothèse implantable
US4648880A (en) * 1984-08-30 1987-03-10 Daniel Brauman Implantable prosthetic devices
FR2619706A1 (fr) * 1987-09-02 1989-03-03 Chachques Juan Carlos Dispositif chirurgicalement implantable pour la formation d'un neo-ventricule
EP0318193A2 (fr) * 1987-11-25 1989-05-31 Dow Corning Wright Corporation Méthodes de fabrication de réservoirs gonflables implantables en silicone
JPH01166756A (ja) * 1987-11-25 1989-06-30 Dow Corning Wright Corp 移植できる膨張性性シリコーンレザバーの製造方法
EP0318193A3 (fr) * 1987-11-25 1990-05-23 Dow Corning Wright Corporation Méthodes de fabrication de réservoirs gonflables implantables en silicone
WO1996003940A1 (fr) * 1994-08-05 1996-02-15 Innovative Technologies Limited Protheses mammaires
EP0904088A1 (fr) * 1996-10-18 1999-03-31 Life Medical Sciences, Inc. Coussin de silicone rempli de gaz ou de gel pour traiter les cheloides et les cicatrices hypertrophiques
EP0904088A4 (fr) * 1996-10-18 2001-09-26 Technion Res And Dev Of Founda Coussin de silicone rempli de gaz ou de gel pour traiter les cheloides et les cicatrices hypertrophiques
WO2006137695A1 (fr) * 2005-06-22 2006-12-28 Korea Institute Of Machinery And Materials Bruleur destine a la regeneration de filtre contre les matieres en suspension d’un moteur diesel
WO2009018105A1 (fr) * 2007-07-27 2009-02-05 Allergan, Inc. Prothèse mammaire remplie de gel élastomère formant barrière
EP2735285A1 (fr) * 2007-07-27 2014-05-28 Allergan, Inc. Prothèse mammaire avec gel et barrière elastomerique
EP3150168A1 (fr) * 2007-07-27 2017-04-05 Allergan, Inc. Prothèse mammaire remplie de gel élastomère formant barrière
EP3677222A1 (fr) * 2007-07-27 2020-07-08 Allergan, Inc. Prothèse mammaire remplie de gel élastomère formant barrière
WO2010045581A1 (fr) * 2008-10-17 2010-04-22 Allergan, Inc. Enveloppe d'implant prothétique
WO2010045579A2 (fr) * 2008-10-17 2010-04-22 Allergan, Inc. Enveloppe d'implant prothétique
WO2010045579A3 (fr) * 2008-10-17 2010-12-02 Allergan, Inc. Enveloppe d'implant prothétique
EP3130313A1 (fr) * 2008-10-17 2017-02-15 Allergan, Inc. Procédé de détection des ruptures dans un implant prothétique
WO2011022235A3 (fr) * 2009-08-18 2011-06-16 Allergan, Inc. Implant prothétique renforcé avec enveloppe souple
US9486308B2 (en) 2009-08-18 2016-11-08 Allergan, Inc. Method of making a reinforced prosthetic implant with flexible shell
US10251746B2 (en) 2009-08-18 2019-04-09 Allergan, Inc. Method of making reinforcing prosthetic implant with flexible shell

Also Published As

Publication number Publication date
JPS6110137B2 (fr) 1986-03-28
BR8008981A (pt) 1981-10-20
EP0030838B1 (fr) 1984-03-07
JPS56501711A (fr) 1981-11-26
CA1199451A (fr) 1986-01-21
WO1981001650A1 (fr) 1981-06-25

Similar Documents

Publication Publication Date Title
EP0030838B1 (fr) Article en caoutchouc de silicone rempli d'un gel de silicone avec exsudation réduite
US4100627A (en) Low oiling gel filled flexible articles and gels therefor
KR102139876B1 (ko) 피부 접착성 실리콘 겔
EP0029292B1 (fr) Prothèse remplie de gel de silicone; procédé pour sa fabrication
US4472226A (en) Silicone gel filled prosthesis
US5534609A (en) Polysiloxane compositions
CA2740890A1 (fr) Enveloppe d'implant prothetique
US4222983A (en) Impression compositions and process for preparing impressions
US5145933A (en) Organosiloxane gel-forming compositions and use thereof
JP3153876B2 (ja) 発泡性シリコーン組成物
EP0322118B1 (fr) Compositions gélifiables à base d'organosiloxanes et leur utilisation
EP0506241A1 (fr) Mousse de siloxane
EP0205349A2 (fr) Barrières imperméables et leur utilisation dans des implants corporels
US3829903A (en) Method of inhibiting blood clot on silicone rubber medical devices
AU595452B2 (en) Multiple release mold coating for high water, high resiliency polyurethane foam
JPH02151658A (ja) 水を除去することによって架橋してエラストマーになる、アルケニルオキシシランを基とするシリコーンの水性分散体
CN108350339A (zh) 可以交联生成硅凝胶的硅酮组合物
US10702625B2 (en) Skin-adhesive item
GB1582081A (en) Gel filled flexible articles and gels therefor
MXPA06011951A (es) Fabricacion en linea de guantes de goma libres de polvo.
KR102139877B1 (ko) 피부 접착성 실리콘 겔
JPS58225152A (ja) 硬化性オルガノポリシロキサン組成物
JP2022504426A (ja) 特に医療機器で使用するためのカスタマイズ可能な疑似肉シリコーンゲル又はシリコーンフォームを作製するためのキット
JPH04227730A (ja) メチルヒドロシロキサン類を硬化及び架橋させる方法
WO2011022367A2 (fr) Matériau d'impression dentaire

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

AK Designated contracting states

Designated state(s): BE DE FR GB IT

17P Request for examination filed

Effective date: 19811128

RBV Designated contracting states (corrected)

Designated state(s): BE IT

ITF It: translation for a ep patent filed

Owner name: UFFICIO BREVETTI RAPISARDI S.R.L.

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

AK Designated contracting states

Designated state(s): BE IT

PLBE No opposition filed within time limit

Free format text: ORIGINAL CODE: 0009261

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT

26N No opposition filed
ITTA It: last paid annual fee
PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: BE

Payment date: 19921120

Year of fee payment: 13

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: BE

Effective date: 19931231

BERE Be: lapsed

Owner name: DOW CORNING CORP.

Effective date: 19931231